EU Provides Horizon Discovery $1.7M to Develop Cancer Models

The UK firm also joined the COLTHERES Consortium, tasked to define and carry out biomarker-driven clinical trials with the goal of improving cancer therapy outcomes.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories